These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6671465)

  • 1. In vitro effect of androgen on RNA synthesis in nuclei from androgen-independent subline of Shionogi carcinoma (CS 2).
    Suzuki N; Urata M; Miyauchi T; Wakisaka M; Shimazaki J; Hosoya T
    Endocrinol Jpn; 1983 Oct; 30(5):657-61. PubMed ID: 6671465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of sex hormones on RNA synthesis of androgen-dependent mouse mammary tumor (Shionogi carcinoma).
    Suzuki N; Wakisaka M; Miyauchi T; Shimazaki J; Hosoya T
    Endocrinol Jpn; 1983 Feb; 30(1):15-21. PubMed ID: 6884272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of androgen on ornithine decarboxylase activity in androgen-dependent mouse mammary tumor (Shionogi Carcinoma 115) and its androgen-independent subline (CS 2).
    Suzuki N; Miyauchi T; Urata M; Yazawa H; Shimazaki J; Hosoya T
    Endocrinol Jpn; 1986 Apr; 33(2):233-8. PubMed ID: 3757919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor, testosterone uptake and karyotype in androgen-dependent mouse tumor (SC 115) and its androgen-independent subline (CS 2).
    Zama S; Akimoto S; Yazawa S; Ichikawa T; Hayata I; Petrow V; Shimazaki J
    Endocrinol Jpn; 1987 Apr; 34(2):279-89. PubMed ID: 3622394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical findings on androgen receptor in mouse androgen-dependent tumor (Shionogi Carcinoma 115) and its independent sublines.
    Masai M; Suzuki H; Kuramochi H; Mikami H; Shimazaki J
    Endocr J; 1994 Dec; 41(6):709-15. PubMed ID: 7704096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression and selection in heterogeneous tumor composed of androgen-responsive Shionogi carcinoma 115 and its autonomous subline (Chiba subline 2).
    Ichikawa T; Akimoto S; Hayata I; Shimazaki J
    Cancer Res; 1989 Jan; 49(2):367-71. PubMed ID: 2910455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).
    Fujita MQ; Yasui T; Sato B; Uchida N; Uchida K; Shiratori O; Takeda K; Matsumoto K
    Jpn J Cancer Res; 1992 Sep; 83(9):995-1001. PubMed ID: 1429212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of androgen dependency with preservation of functional androgen receptors in androgen-dependent mouse tumor (Shionogi Carcinoma 115).
    Furuya Y; Shirasawa H; Sato N; Watabe Y; Simizu B; Shimazaki J
    J Steroid Biochem Mol Biol; 1992 Jul; 42(6):569-74. PubMed ID: 1637720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in cytosolic androgen receptor after administration of testosterone of androgen-dependent mouse mammary tumor (Shionogi carcinoma) and its sublines of altered androgen dependency.
    Fuse H; Akimoto S; Sato R; Miyauchi T; Wakisaka M; Hosoya T; Shimazaki J
    Endocrinol Jpn; 1983 Apr; 30(2):189-97. PubMed ID: 6605848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of estrogen enhancement in the growth of androgen-dependent Shionogi carcinoma 115.
    Noguchi S; Takatsuka D; Kitamura Y; Terada N; Uchida N; Yamaguchi K; Sato B; Matsumoto K
    Cancer Res; 1985 Oct; 45(10):4785-90. PubMed ID: 4027967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appearance of malignant phenotype with partial loss of hormone dependency in androgen-dependent Shionogi Carcinoma 115 transfected with hst-1 gene.
    Furuya Y; Sato N; Watabe Y; Shimazaki J
    Jpn J Cancer Res; 1991 Nov; 82(11):1245-51. PubMed ID: 1836456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paracrine growth stimulation of androgen-responsive Shionogi Carcinoma 115 by its autonomous subline (Chiba Subline 2).
    Furuya Y; Sato N; Akakura K; Ichikawa T; Suzuki N; Sato R; Shimazaki J
    Cancer Res; 1990 Aug; 50(16):4979-83. PubMed ID: 2379162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modalities of chemotherapy and endocrine therapy for growth inhibition of androgen-stimulated mouse carcinoma (Shionogi carcinoma 115).
    Hara S; Ichikawa T; Akimoto S; Wakisaka M; Shimazaki J
    Prostate; 1987; 11(2):107-15. PubMed ID: 3671190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor system in androgen-independent mouse tumor developed from androgen-dependent Shionogi carcinoma 115.
    Seike H; Takeuchi M; Kitamura Y; Sato B; Yamaguchi K; Matsumoto K
    Anticancer Res; 1983; 3(1):35-9. PubMed ID: 6830149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S; Kitamura Y; Uchida N; Yamaguchi K; Sato B; Matsumoto K
    Cancer Res; 1984 Dec; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of serial passage in female nude athymic mice on androgen dependency of Shionogi carcinoma 115.
    Kitamura Y; Uchida N; Hayata I; Yamaguchi K; Okamoto S; Narita N; Matsumoto K
    Cancer Res; 1980 Dec; 40(12):4781-5. PubMed ID: 7438110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
    Nickerson T; Miyake H; Gleave ME; Pollak M
    Cancer Res; 1999 Jul; 59(14):3392-5. PubMed ID: 10416600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intermittent androgen suppression on the stem cell composition and the expression of the TRPM-2 (clusterin) gene in the Shionogi carcinoma.
    Akakura K; Bruchovsky N; Rennie PS; Coldman AJ; Goldenberg SL; Tenniswood M; Fox K
    J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):501-11. PubMed ID: 9010356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth control of androgen-dependent Shionogi carcinoma cells by growth factor(s) produced from androgen-independent Shionogi carcinoma cells in a paracrine mechanism.
    Noguchi S; Uchida N; Sato B; Koyama H; Matsumoto K
    J Steroid Biochem; 1989 Apr; 32(4):479-83. PubMed ID: 2724951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.